Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Accounts Payables (2020 - 2025)

Historic Accounts Payables for KORU Medical Systems (KRMD) over the last 10 years, with Q3 2025 value amounting to $1.9 million.

  • KORU Medical Systems' Accounts Payables rose 1208.54% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 1208.54%. This contributed to the annual value of $1.6 million for FY2024, which is 6919.41% up from last year.
  • Latest data reveals that KORU Medical Systems reported Accounts Payables of $1.9 million as of Q3 2025, which was up 1208.54% from $1.1 million recorded in Q2 2025.
  • KORU Medical Systems' Accounts Payables' 5-year high stood at $2.4 million during Q4 2022, with a 5-year trough of $945619.0 in Q3 2023.
  • In the last 5 years, KORU Medical Systems' Accounts Payables had a median value of $1.6 million in 2023 and averaged $1.6 million.
  • Per our database at Business Quant, KORU Medical Systems' Accounts Payables soared by 13764.28% in 2022 and then tumbled by 5922.76% in 2023.
  • Over the past 5 years, KORU Medical Systems' Accounts Payables (Quarter) stood at $1.2 million in 2021, then soared by 94.85% to $2.4 million in 2022, then crashed by 59.23% to $975193.0 in 2023, then skyrocketed by 69.19% to $1.6 million in 2024, then grew by 13.47% to $1.9 million in 2025.
  • Its Accounts Payables stands at $1.9 million for Q3 2025, versus $1.1 million for Q2 2025 and $2.0 million for Q1 2025.